secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2023-09-06T23:59:59+00:00
Accession:  0001615219-23-000067
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------------

- Nasdaq notified Salarius on Sept 5, 2023 that average closing bid price fell below $1.00 over prior 30 consecutive trading days.
- Company has 180 calendar days (until March 4, 2024) to regain compliance by having bid price >= $1.00 for 10 consecutive business days.
- If not compliant by March 4, 2024, Salarius may qualify for additional 180-day period if it meets other Nasdaq listing standards.
- Company intends to monitor closing bid price and evaluate options to regain compliance; no immediate effect on listing or trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521923000067/0001615219-23-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521923000067/flks-20230905.htm
  HTML page:      https://secwatch.observer/filing/0001615219-23-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer